CClinicalTrials.gg
RecruitingNCT06864715LIVE-WELUpdated Apr 28, 2026

Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors

An interventional study of Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S) and Treatment as Usual in Post-stroke Depression and Subthreshold Depression, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

The overall objective of the project is to determine the effectiveness of tele-delivered behavioral activation (BA) by trained lay counselors (Tele-BA-S) to prevent Post-stroke depression (PSD) in low-income, older stroke survivors with subthreshold depression (SD).

02

Conditions studied

  • Post-stroke Depression
  • Subthreshold Depression
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Enrollment within 3-months +2 weeks of a first-time ischemic or hemorrhagic stroke
  • 24-item HDRS score \< 15 indicating subthreshold depression defined as the absence of depressive symptoms or presence of mild symptoms of depression
  • Single person income less than or equal to $45,000
  • Residing in a community residence
  • Ability to speak and read in English or Spanish
  • Mini-MoCA score > or equal to 11

Exclusion criteria

Exclusion Criteria:

  • Stroke event unrelated to vascular risk factors (e.g., drug use) or transient ischemic attack
  • 24-item HDRS score > or equal to 15 indicating moderate to severe depression
  • Actively participating in psychotherapy
  • high suicide risk or severe psychiatric illness (e.g., bipolar disorder and active psychosis) and/or actively taking antipsychotics
  • Diagnosed dementia and/or currently taking cognitive enhancers, amyloid-targeting medications, or orexin receptor antagonists
  • Patient Health Questionnaire 9 score > or equal to 10 and/or answers positive to Q9
  • Diagnosed aphasia and/or severe cognitive impairments
  • high-risk alcohol or drug misuse
  • receiving medications for mood disorders and a change in dose or type within the last 4 weeks
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

    Behavioral: Tele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

  • Active comparator
    Treatment as Usual

    Behavioral: Treatment as Usual

Interventions

  • BehavioralTele-delivered Behavioral Activation by lay counselors after Stroke (Tele-BA-S)

    The Tele-BA-S intervention will comprise 5 weekly video-conferenced BA sessions delivered by trained lay counselors, homework, and 2 monthly follow-up booster calls. Participants will receive the standard hospital discharge post-stroke educational packet and a scheduled follow-up appointment with a stroke practitioner to evaluate patients at 7-14 days and 3 months ±14 days, according to current standard of care. They will be seen over video or in-person, according to their preference and capabilities.

  • BehavioralTreatment as Usual

    Participants will receive the standard hospital discharge post-stroke educational packet and a scheduled follow-up appointment with a stroke practitioner to evaluate patients at 7-14 days and 3 months ±14 days, according to current standard of care. They will be seen over video or in-person, according to their preference and capabilities.

06

What researchers measure

Primary outcomes

  1. Post-Stroke Depression as Assessed by Score on the Hamilton Depression Rating Scale (HDRS) 24-item

    Total score on the 24-item HDRS ranges from 0 to 52, with a higher score indicating greater depression.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  2. Subthreshold Depression (Depressive Symptoms) as Assessed by the Patient Health Questionnaire (PHQ-9)

    Total score on the PHQ-9 ranges from 0 to 27, with a higher score indicating greater depression.

    Time frame: baseline, 1 month, 2 months, 4 months, 6 months, 9 months

Secondary outcomes

  1. Anxiety as Assessed by the Generalized Anxiety Disorder- 7 Item (GAD-7)

    Total score on the GAD-7 ranges from 0 to 15, with a higher score indicating greater anxiety.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  2. Change in Emotional Distress as Assessed by the Ryff Psychological Well-being Scale (PWB)

    Emotional distress will be evaluated using the Ryff Psychological Well-Being Scale (PWB), a validated self-report instrument measuring psychological well-being across six domains: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Participants rate agreement with statements on a 6-point Likert scale ranging from strongly disagree to strongly agree. Scores are calculated for each domain and/or as a total composite score, with higher scores indicating greater psychological well-being (lower emotional distress).

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  3. Quality of Life (QOL) as Assessed by the Short Form Stroke Specific Quality of Life Scale (SS-QOL)

    Total score on the SS-QOL ranges from 12-60, with a higher score indicating better functioning.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  4. Number of Self-Reported Emergency Room Visits Over the Course of the Study

    calculated number of emergency room visits over course of study

    Time frame: From baseline to 9 months

  5. Number of Hospitalizations Over the Course of the Study

    calculated number of hospitalizations over course of study

    Time frame: From baseline to 9 months

  6. Disability as Assessed by the Modified Rankin Scale (mRS)

    Total score on the mRS ranges from 0-6, with a higher score indicating greater disability.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  7. Medication Adherence Report Scale-5

    Total score ranges from 5 to 25, with higher scores indicating higher self-reported adherence.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  8. Rehabilitation Adherence Inventory

    Greater total scores indicate greater adherence.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

  9. Barthel Index

    Total scores range from 0 to 100, with lower scores indicating higher dependency.

    Time frame: baseline, 2 months, 4 months, 6 months, 9 months

07

Study locations

1 of 1 sites recruiting
  • The University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
    Recruiting
08

References and documents

Publications

  • Beauchamp JES, Savitz SI, Sharrief A, Reininger BM, Acierno R, Suchting R, Burnett J, Rosales L, Albaqali JA, Rajan R, Choi NG. Behavioural activation for the prevention of poststroke depression in low-income older stroke survivors (LIVE WEL): protocol for a randomised controlled trial. BMJ Open. 2026 Jun 7;16(6):e120452. doi: 10.1136/bmjopen-2026-120452. PubMed 42252135 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06864715
Lead sponsor
The University of Texas Health Science Center, Houston
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Jennifer Beauchamp (Associate Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Mar 7, 2025
Start date
Apr 10, 2026
Primary completion
Nov 1, 2029 (estimated)
Completion
Nov 1, 2029 (estimated)
Last update
Apr 28, 2026

Study contacts

Jennifer Beauchamp, PhD, RN
Contact
Jennifer.e.Beauchamp@uth.tmc.edu
713-500-2114
Jennifer Beauchamp, PhD, RN
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion